In drug development, simulations can predict how cancer cells will respond to new drugs. This involves creating virtual models of cancer cells and testing the drugs in silico before moving to in vitro or in vivo studies. This approach can significantly reduce the time and cost associated with bringing new drugs to market. It also helps in identifying potential side effects early in the development process.
